1. Home
  2. BIO vs CYTK Comparison

BIO vs CYTK Comparison

Compare BIO & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CYTK
  • Stock Information
  • Founded
  • BIO 1952
  • CYTK 1997
  • Country
  • BIO United States
  • CYTK United States
  • Employees
  • BIO N/A
  • CYTK N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • BIO Industrials
  • CYTK Health Care
  • Exchange
  • BIO Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • BIO 6.0B
  • CYTK 5.6B
  • IPO Year
  • BIO N/A
  • CYTK 2004
  • Fundamental
  • Price
  • BIO $257.04
  • CYTK $37.01
  • Analyst Decision
  • BIO Strong Buy
  • CYTK Buy
  • Analyst Count
  • BIO 4
  • CYTK 14
  • Target Price
  • BIO $324.25
  • CYTK $70.92
  • AVG Volume (30 Days)
  • BIO 374.5K
  • CYTK 1.4M
  • Earning Date
  • BIO 07-31-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • BIO N/A
  • CYTK N/A
  • EPS Growth
  • BIO N/A
  • CYTK N/A
  • EPS
  • BIO N/A
  • CYTK N/A
  • Revenue
  • BIO $2,541,100,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • BIO N/A
  • CYTK $34.81
  • Revenue Next Year
  • BIO $3.49
  • CYTK $643.79
  • P/E Ratio
  • BIO N/A
  • CYTK N/A
  • Revenue Growth
  • BIO N/A
  • CYTK 412.21
  • 52 Week Low
  • BIO $211.43
  • CYTK $29.31
  • 52 Week High
  • BIO $387.99
  • CYTK $61.38
  • Technical
  • Relative Strength Index (RSI)
  • BIO 65.41
  • CYTK 65.31
  • Support Level
  • BIO $245.87
  • CYTK $33.07
  • Resistance Level
  • BIO $264.68
  • CYTK $36.99
  • Average True Range (ATR)
  • BIO 7.34
  • CYTK 1.32
  • MACD
  • BIO 1.84
  • CYTK 0.44
  • Stochastic Oscillator
  • BIO 78.94
  • CYTK 99.11

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: